Iovance Biotherapeutics, Inc. (IOVA)
2.25
-0.06
(-2.60%)
USD |
NASDAQ |
Dec 09, 16:00
2.24
-0.01
(-0.44%)
After-Hours: 18:24
Iovance Biotherapeutics Total Liabilities (Quarterly): 202.66M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | 13.62M |
| Talphera, Inc. | 11.56M |
| Lantheus Holdings, Inc. | 1.157B |
| iRhythm Technologies, Inc. | 873.32M |
| Day One Biopharmaceuticals, Inc. | 62.91M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 904.95M |
| Shareholders Equity (Quarterly) | 702.29M |
| Debt to Equity Ratio | 0.0747 |
| Current Ratio | 3.411 |
| Net Debt Paydown Yield | 0.70% |